ABVC BIOPHARMA, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q3 2011 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
-
Summary
-
Abvc Biopharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q3 2011 to Q2 2025.
- Abvc Biopharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2025 was $6.76M, a 8.32% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)